Annette B. Beiderbeck

Author

Pharmo Institute

Also Known As

A Beiderbeck, A. B. Beiderbeck, A. Beiderbeck, Annette B. Beiderbeck, Annette Beiderbeck, Beiderbeck, Annette

Publications

822

Citations

H-Index

Concepts

All Affiliations

Pharmo Institute GlaxoSmithKline (United Kingdom)Boston University Aarhus University Hospital Erasmus University Rotterdam

About

Annette B. Beiderbeck is an author at Pharmo Institute specializing in medicine, public health, and pharmacoepidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	61
2	Public Health	2	2	48
3	Health Sciences	1	1	13
4	Diabetes	1	1	13
5	Epidemiology	1	1	33

Annette B. Beiderbeck

Publications

810

Citations

H-Index

Page 1

	Year	Citations
The Risk of Cancer in Users of Statins Matthijs R. Graaf, Annette B. Beiderbeck, Toine C. G. Egberts, Journal of Clinical Oncology	2004	523
The incidence of interstitial lung disease 1995–2005: a Danish nationwide population-based study Jette Brommann Kornum, Steffen Christensen, Miriam Grijota, BMC Pulmonary Medicine	2008	104
No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands) Annette B. Beiderbeck, Elizabeth A. Holly, Miriam Sturkenboom, Cancer Causes & Control	2003	45
Prescription Medications Associated with a Decreased Risk of Non-Hodgkin's Lymphoma Annette B. Beiderbeck American Journal of Epidemiology Epidemiology Of CancerPrescription MedicationsPharmacotherapyLogistic AnalysisAdverse Drug Reaction	2003	33
Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy Marianne Ulcickas Yood, Karen Wells, Sharon Hensley Alford, Pharmacoepidemiology and Drug Safety	2012	19
Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies Michał Pochopień, Annette B. Beiderbeck, Phil McEwan, BMC Health Services Research	2019	19
Misclassification of exposure is high when interview data on drug use are used as a proxy measure of chronic drug use during follow-up Annette B. Beiderbeck, Miriam Sturkenboom, J.W.W. Coebergh, Journal of Clinical Epidemiology Substance AbuseSubstance UsePsychiatryHealth PolicyAddiction	2004	15
Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study Steffen Christensen, Lars Pedersen, Miriam Grijota, British Journal of Cancer	2008	14
Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practice Myrthe P. P. van Herk‐Sukel, Nancy S. Breekveldt‐Postma, Joëlle A. Erkens, Pharmacoepidemiology and Drug Safety	2007	13
Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN®) versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema Fahd Quhill, Annette B. Beiderbeck Global & Regional Health Technology Assessment Ophthalmic SurgeryOcular DiseaseFluocinolone Acetonide ImplantSurgeryRetinal Therapies	2017	13

Page 1